Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice.

PLoS One · 2015 · PMC4648487 · PMID 26575028

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Effective and highly significant protection was demonstrated in mice immunized with TgMIC1-4-6 or TgMIC1-4, since 80% and 70% of the mice, respectively, survived to the acute phase of infection, which is compatible with the high protection reported to be conferred by immunization with the LAC+ fraction (21).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.